Evidence map›Paper›PMID 36795064›Full record

ArticleTranslational vision science & technology2023

USH2A Gene Mutations in Rabbits Lead to Progressive Retinal Degeneration and Hearing Loss.

Van Phuc Nguyen, Jun Song, Diane Prieskorn, Junhuang Zou, Yanxiu Li, David Dolan, Jie Xu, Jifeng Zhang, K Thiran Jayasundera, Jun Yang and 7 more

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. AAV-mediated exon skipping therapy for Usher syndrome, type 2A.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. HGG advances · 2023
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Van Phuc NguyenW.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Jun SongCenter for Advanced Models for Translational Sciences and Therapeutics, University of Michigan, Ann Arbor, MI, USA.
Diane PrieskornKresge Hearing Research Institute, Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI, USA.
Junhuang ZouJohn A. Moran Eye Center, Department of Ophthalmology, University of Utah Medical School, Salt Lake City, UT, USA.
Yanxiu LiW.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
David DolanKresge Hearing Research Institute, Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI, USA.
Jie XuCenter for Advanced Models for Translational Sciences and Therapeutics, University of Michigan, Ann Arbor, MI, USA.
Jifeng ZhangCenter for Advanced Models for Translational Sciences and Therapeutics, University of Michigan, Ann Arbor, MI, USA.
K Thiran JayasunderaW.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Jun YangJohn A. Moran Eye Center, Department of Ophthalmology, University of Utah Medical School, Salt Lake City, UT, USA.
Yehoash RaphaelKresge Hearing Research Institute, Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI, USA.
Naheed KhanW.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Michael IannuzziGeneToBe Inc, Ann Arbor, MI, USA.
Charles BisgaierGeneToBe Inc, Ann Arbor, MI, USA.
Y Eugene ChenCenter for Advanced Models for Translational Sciences and Therapeutics, University of Michigan, Ann Arbor, MI, USA.
Yannis M PaulusW.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.
Dongshan YangCenter for Advanced Models for Translational Sciences and Therapeutics, University of Michigan, Ann Arbor, MI, USA.
University of Michigan · USUniversity of Utah · US

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
VIVARIUM MODULEP30EY007003 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti · 1987 to 2026
$17.6M
University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Bryan William Jones · 2005 to 2026
$14.6M
IDOL and dyslipidemia in cardiovascular diseasesR01HL147527 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHEN, YUQING EUGENE · 2019 to 2022
$3.1M
Development of Nanoneedle Array for Painless and Long-Term Sustained Intraocular Drug DeliveryR01EY033000 · NEI · PURDUE UNIVERSITY · PI LEE, CHI HWAN, PAULUS, YANNIS MANTAS · 2021 to 2025
$1.9M
Function of C8ORF37 in PhotoreceptorsR01EY026521 · NEI · UNIVERSITY OF UTAH · PI YANG, JUN · 2017 to 2020
$1.7M
Real-time In Vivo Visualization of the Molecular Processes in Choroidal NeovascularizationK08EY027458 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PAULUS, YANNIS MANTAS · 2018 to 2021
$898k
A novel rabbit model for easy monoclonal antibody productionR21GM140359 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASCALHO, MARILIA ISABEL, YANG, DONGSHAN · 2020 to 2021
$429k
Understanding the functions of USH2A and ADGRV1 in photoreceptors by identifying their interacting proteinsR21EY030198 · NEI · UNIVERSITY OF UTAH · PI YANG, JUN · 2020 to 2021
$414k
Development of an Usher Gene TherapyR43EY031603 · NEI · GREFFEX, INC. · PI STAERZ, UWE D, YANG, JUN · 2021 to 2022
$337k
Novel Nanosecond Laser and Ultrasound to Selectively Treat Eye Blood VesselsR41EY031219 · NEI · PHOTOSONOX LLC · PI PAULUS, YANNIS MANTAS · 2020 to 2020
$225k
NCATS NIH HHS UL1 TR002538NEI NIH HHS K08 EY027458NEI NIH HHS P30 EY007003NEI NIH HHS P30 EY014800NEI NIH HHS R01 EY026521NEI NIH HHS R01 EY033000NEI NIH HHS R21 EY030198NEI NIH HHS R41 EY031219NEI NIH HHS R43 EY031603NHLBI NIH HHS R01 HL147527NIGMS NIH HHS R21 GM140359
6 · The paper itself

Abstract

Purpose: Mutations in USH2A gene are responsible for the greatest proportion of the Usher Syndrome (USH) population, among which more than 30% are frameshift mutations on exon 13. A clinically relevant animal model has been absent for USH2A-related vision loss. Here we sought to establish a rabbit model carrying USH2A frameshift mutation on exon 12 (human exon 13 equivalent). Methods: CRISPR/Cas9 reagents targeting the rabbit USH2A exon 12 were delivered into rabbit embryos to produce an USH2A mutant rabbit line. The USH2A knockout animals were subjected to a series of functional and morphological analyses, including acoustic auditory brainstem responses, electroretinography, optical coherence tomography, fundus photography, fundus autofluorescence, histology, and immunohistochemistry. Results: The USH2A mutant rabbits exhibit hyper-autofluorescent signals on fundus autofluorescence and hyper-reflective signals on optical coherence tomography images as early as 4 months of age, which indicate retinal pigment epithelium damage. Auditory brainstem response measurement in these rabbits showed moderate to severe hearing loss. Electroretinography signals of both rod and cone function were decreased in the USH2A mutant rabbits starting from 7 months of age and further decreased at 15 to 22 months of age, indicating progressive photoreceptor degeneration, which is confirmed by histopathological examination. Conclusions: Disruption of USH2A gene in rabbits is sufficient to induce hearing loss and progressive photoreceptor degeneration, mimicking the USH2A clinical disease. Translational Relevance: To our knowledge, this study presents the first mammalian model of USH2 showing the phenotype of retinitis pigmentosa. This study supports the use of rabbits as a clinically relevant large animal model to understand the pathogenesis and to develop novel therapeutics for Usher syndrome.

Indexed as

Retinal DegenerationRetinitis PigmentosaUsher SyndromesAnimalsExtracellular Matrix ProteinsHumansMammalsMutationRabbitsExtracellular Matrix ProteinsUSH2A protein, human

Identifiers

PMID36795064
PMCPMC9940772
OpenAlexW4321003263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.